McGill University, Montreal, QC, H3T 1E2 Canada.
Contraception. 2012 Jan;85(1):51-5. doi: 10.1016/j.contraception.2011.05.002. Epub 2011 Jul 20.
In 2005, 97,254 abortions were performed in Canada, of which 38% were repeat abortions. The objective of this research was to determine if provision of free intrauterine devices (IUDs) postabortion is associated with a reduction in health-care costs and repeat abortions in a Canadian population compared with provision of oral contraceptives (OCPs) or depo-medroxyprogesterone acetate (DMPA).
A retrospective cohort study was conducted by intention-to-treat chart review in a facility providing the majority of abortions in a Canadian health region. All (n=1782) residents of this region who underwent abortion in 2003, 2004 and 2008 were included. One- and 5-year rates of repeat abortion were calculated, and a cost-effectiveness analysis was conducted to compare health-care system costs of providing patients with IUDs, OCPs or DMPA and subsequent repeat abortions.
In 2003 and 2004, 1101 index abortions occurred. The main contraceptive cohorts were immediate IUD insertion (n=117, 10.6%), immediate OCP (n=413, 37.5%) and immediate DMPA administration (n=357, 32.4%). After 5 years repeat abortion rates in the respective cohorts were: IUD, 9.4%, OCP, 17.4%, DMPA, 16.2% (p=.05). One-year rates of repeat abortion were not significantly different. Costs of providing contraception and subsequent abortions over 5 years were $142.63 (IUD), $385.61 (OCP) and $384.81 (DMPA) per user.
The immediate insertion of IUDs postabortion is associated with a lower 5-year rate of repeat abortion than provision of OCPs or DMPA. A cost reduction to the health-care system occurs when providing IUDs postabortion vs. alternate contraception of equivalent duration.
2005 年,加拿大共实施了 97254 例人工流产,其中 38%为重复流产。本研究旨在确定与提供口服避孕药(OCP)或醋酸甲羟孕酮(DMPA)相比,为流产后患者提供宫内节育器(IUD)是否会降低加拿大人群的医疗成本和重复流产率。
通过意向治疗图表审查,对加拿大某卫生区域内提供大多数流产服务的机构进行了回顾性队列研究。纳入了该区域内所有(n=1782)在 2003 年、2004 年和 2008 年进行流产的居民。计算了 1 年和 5 年的重复流产率,并进行了成本效益分析,以比较为患者提供 IUD、OCP 或 DMPA 以及随后的重复流产的医疗保健系统成本。
2003 年和 2004 年共发生了 1101 例指数流产。主要避孕药物组为立即放置 IUD(n=117,10.6%)、立即使用 OCP(n=413,37.5%)和立即注射 DMPA(n=357,32.4%)。在各自的队列中,5 年后重复流产率分别为:IUD 组 9.4%、OCP 组 17.4%、DMPA 组 16.2%(p=.05)。1 年内重复流产率无显著差异。5 年内提供避孕措施和随后流产的成本分别为每个患者 142.63 美元(IUD)、385.61 美元(OCP)和 384.81 美元(DMPA)。
与提供 OCP 或 DMPA 相比,流产后立即放置 IUD 与较低的 5 年重复流产率相关。与同等持续时间的替代避孕方法相比,为流产后患者提供 IUD 会降低医疗保健系统的成本。